Alector Insider Arnon Rosenthal Updates Stock Holdings in SC 13G

Ticker: ALEC · Form: SC 13G · Filed: 2024-02-08T00:00:00.000Z

Sentiment: neutral

Topics: insider-ownership, SC-13G, amendment, biotech

Related Tickers: ALEC

TL;DR

**Insider Arnon Rosenthal updated his Alector stock ownership, signaling current stake.**

AI Summary

Arnon Rosenthal, a key individual associated with Alector, Inc., filed an Amendment No. 2 to his SC 13G on February 8, 2024, indicating his beneficial ownership of Alector's common stock as of December 31, 2023. This filing, made under Rule 13d-1(d), updates his previous disclosures. For investors, this matters because it provides transparency into the holdings of an insider, which can signal confidence or lack thereof in the company's future prospects.

Why It Matters

This filing provides an updated snapshot of an insider's stake in Alector, Inc., offering a glimpse into their conviction about the company's value and future performance.

Risk Assessment

Risk Level: low — This is a routine disclosure filing by an insider, not indicating any immediate high-risk events.

Analyst Insight

A smart investor would note this routine insider disclosure and cross-reference it with previous filings to track changes in Arnon Rosenthal's ownership, looking for significant increases or decreases that might signal a shift in insider confidence.

Key Players & Entities

FAQ

What type of filing is this document?

This document is an SC 13G, specifically Amendment No. 2, filed under Rule 13d-1(d) of the Securities Exchange Act of 1934.

Who is the reporting person in this SC 13G filing?

The reporting person is Arnon Rosenthal, whose citizenship is listed as United States.

What is the name of the issuer whose securities are being reported?

The issuer is Alector, Inc., with a CUSIP Number of 014442 107.

What is the title of the class of securities being reported?

The title of the class of securities is Common Stock, with a $0.0001 par value per share.

What was the date of the event that required this filing?

The date of the event which requires the filing of this statement was December 31, 2023.

From the Filing

0000950170-24-012943.txt : 20240208 0000950170-24-012943.hdr.sgml : 20240208 20240208185902 ACCESSION NUMBER: 0000950170-24-012943 CONFORMED SUBMISSION TYPE: SC 13G PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20240208 DATE AS OF CHANGE: 20240208 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: Alector, Inc. CENTRAL INDEX KEY: 0001653087 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 822933343 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G SEC ACT: 1934 Act SEC FILE NUMBER: 005-90858 FILM NUMBER: 24610691 BUSINESS ADDRESS: STREET 1: 131 OYSTER POINT BLVD., SUITE 600 CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 BUSINESS PHONE: 415-231-5660 MAIL ADDRESS: STREET 1: 131 OYSTER POINT BLVD., SUITE 600 CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 FORMER COMPANY: FORMER CONFORMED NAME: Alector LLC DATE OF NAME CHANGE: 20150915 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: Rosenthal Arnon CENTRAL INDEX KEY: 0001757770 ORGANIZATION NAME: FILING VALUES: FORM TYPE: SC 13G MAIL ADDRESS: STREET 1: C/O ALECTOR, INC. STREET 2: 151 OYSTER POINT BLVD., #300 CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 SC 13G 1 arnon_2024_schedule_13ga.htm SC 13G SC 13G   UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G UNDER THE SECURITIES EXCHANGE ACT OF 1934 (Amendment No. 2)*   ALECTOR, INC. (Name of Issuer)   Common Stock , $0.0001 par value per share (Title of Class of Securities)   014442 107 (CUSIP Number)   December 31, 2023 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this Schedule is filed:  Rule 13d-1(b)  Rule 13d-1(c)  Rule 13d-1(d) *The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page. The information required on the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).             CUSIP No. 014442 107                     1 NAME OF REPORTING PERSON: Arnon Rosenthal I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY):     2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS): (a)  (b)    3 SEC USE ONLY:   4 CITIZENSHIP OR PLACE OF ORGANIZATION:   United States NUMBER OF SHARES  BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH   5 SOLE VOTING POWER 3,355,398 (1)   6 SHARED VOTING POWER 3,930,375 (2)   7 SOLE DISPOSITIVE POWER 3,355,398 (1)   8 SHARED DISPOSITIVE POWER 3,930,375 (2) 9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON: 7,285,773 (1)(2) 10 CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS):    11 8.5% (3) 12 TYPE OF REPORTING PERSON (SEE INSTRUCTIONS): IN (1) Consists of (i) 1,385,303 shares of common stock held of record by Arnon Rosenthal (the “Reporting Person”) and (ii) 1,970,095 shares of common stock that are issuable upon exercise of outstanding options within 60 days of December 31, 2023 to the Reporting Person. (2) Consists of (i) 1,972,875 shares of common stock held of record by The Rosenthal Family Revocable Trust Dated November 4, 1994, as restated on June 9, 1999, for which the Reporting Person serves as trustee; (ii) 652,500 shares of common stock held

View on Read The Filing